Voloridge Investment Management
ACHN

Voloridge Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Voloridge Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-62,079
Closed -$374K – 1553
2019
Q4 		$374K Buy
+62,079
New +$359K 0.01% 875
2015
Q2 		– Sell
-33,847
Closed -$334K – 410
2015
Q1 		$334K Buy
+33,847
New +$423K 0.02% 240

Voloridge Investment Management's ACHN Position: Q1 2020 in Review

Voloridge Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 62,079 shares — an estimated $374K sold.

Voloridge Investment Management first reported a position in ACHN in Q1 2015 and held it in 2 quarters. The position peaked at $374K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Voloridge Investment Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 62,079 Achillion Pharmaceuticals shares in Q1 2020, an estimated $374K.
  • Voloridge Investment Management first reported a position in Achillion Pharmaceuticals in Q1 2015 and held it in 2 quarters.
  • Voloridge Investment Management's Achillion Pharmaceuticals position peaked at $374K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Voloridge Investment Management's 13F filing for Q1 2020, filed 15 May 2020.